ORIC Pharmaceuticals, a privately held, clinical-stage oncology company focused on developing cancer treatments that address mechanisms of therapeutic resistance, announced today that it will be participating in Citi’s 14th Annual Biotech Conference in Boston.
August 28, 2019
· 1 min read